Longo DL - Search Results

1

Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.

Sing GK, Ruscetti FW, Beckwith M, Keller JR, Ellingsworth L, Urba WJ, Longo DL. Sing GK, et al. Among authors: longo dl. Cell Growth Differ. 1990 Nov;1(11):549-57. Cell Growth Differ. 1990. PMID: 1965139

2

Anti-IgM-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation.

Beckwith M, Urba WJ, Ferris DK, Freter CE, Kuhns DB, Moratz CM, Longo DL. Beckwith M, et al. Among authors: longo dl. J Immunol. 1991 Oct 1;147(7):2411-8. J Immunol. 1991. PMID: 1918971

3

Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines.

Beckwith M, Longo DL, O'Connell CD, Moratz CM, Urba WJ. Beckwith M, et al. Among authors: longo dl. J Natl Cancer Inst. 1990 Mar 21;82(6):501-9. doi: 10.1093/jnci/82.6.501. J Natl Cancer Inst. 1990. PMID: 2313723

4

Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-beta 1.

Goey H, Keller JR, Back T, Longo DL, Ruscetti FW, Wiltrout RH. Goey H, et al. Among authors: longo dl. J Immunol. 1989 Aug 1;143(3):877-80. J Immunol. 1989. PMID: 2745976

5

Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta.

Turley JM, Funakoshi S, Ruscetti FW, Kasper J, Murphy WJ, Longo DL, Birchenall-Roberts MC. Turley JM, et al. Among authors: longo dl. Cell Growth Differ. 1995 Jun;6(6):655-63. Cell Growth Differ. 1995. PMID: 7669719

6

Anti-IgM induces transforming growth factor-beta sensitivity in a human B-lymphoma cell line: inhibition of growth is associated with a downregulation of mutant p53.

Beckwith M, Ruscetti FW, Sing GK, Urba WJ, Longo DL. Beckwith M, et al. Among authors: longo dl. Blood. 1995 May 1;85(9):2461-70. Blood. 1995. PMID: 7727777 Free article.

7

Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.

Grzegorzewski K, Ruscetti FW, Usui N, Damia G, Longo DL, Carlino JA, Keller JR, Wiltrout RH. Grzegorzewski K, et al. Among authors: longo dl. J Exp Med. 1994 Sep 1;180(3):1047-57. doi: 10.1084/jem.180.3.1047. J Exp Med. 1994. PMID: 8064224 Free PMC article.

8

Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15.

Beckwith M, Urba WJ, Longo DL. Beckwith M, et al. Among authors: longo dl. J Natl Cancer Inst. 1993 Mar 17;85(6):483-8. doi: 10.1093/jnci/85.6.483. J Natl Cancer Inst. 1993. PMID: 8445676

9

In vivo and in vitro effects of TGF-beta 1 on normal and neoplastic haemopoiesis.

Ruscetti FW, Dubois C, Falk LA, Jacobsen SE, Sing G, Longo DL, Wiltrout RH, Keller JR. Ruscetti FW, et al. Among authors: longo dl. Ciba Found Symp. 1991;157:212-27; discussion 227-31. doi: 10.1002/9780470514061.ch14. Ciba Found Symp. 1991. PMID: 1649034 Review.

10

Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.

Hornung RL, Pearson JW, Beckwith M, Longo DL. Hornung RL, et al. Among authors: longo dl. Cancer Res. 1992 Jan 1;52(1):101-7. Cancer Res. 1992. PMID: 1727368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

792 results

Search Page

Filters